Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse?-Reference-Cited by-同舟云学术

Natural history of node-negative breast cancer: are conventional prognostic factors predictors of time to relapse?

Published:2002-10 Issue:5 Volume:11 Page:442-448
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Héry Michel,Delozier Thierry,Ramaioli Alain,Julien Jean-Pierre,de Lafontan Brigitte,Petit Thierry,de Ghislain Catherine,Weber Béatrice,Bonneterre Jacques,Teissier Eric

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference38 articles.

1. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases;Carter;Cancer,1989

2. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up;Rosen;J Clin Oncol,1993

3. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years;Rosen;J Clin Oncol,1989

4. Histological grading and prognostic in breast cancer: a study of 1409 cases of which 359 followed for 15 years;Bloom;Br J Cancer,1957

5. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicator of prognosis in node negative breast cancer patients: findings from National Surgical adjuvant Breast and Bowel Project Protocol B-06;Fisher;J Clin Oncol,1988

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and Outcomes for Secondary Breast Cancer in Childhood, Adolescent, and Young Adult Cancer Survivors Treated with Radiation;Cancer Epidemiology Biomarkers & Prevention;2020-08-26

2. Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience;The Breast;2018-02

3. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer;European Journal of Radiology;2016-09

4. Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine;BIOMARK INSIGHTS;2016

5. uPA/PAI-1, Oncotype DX™, MammaPrint®. Valeurs pronostique et prédictive pour une utilité clinique dans la prise en charge du cancer du sein;Bulletin du Cancer;2015-09